"Revolutionizing Parkinson's Classification: A New Biomarker-Based Framework"
Scientists have proposed a new biological classification system for Parkinson's disease, based on specific biological changes associated with the disorder, aiming to move the field closer to precision medicine and the development of disease-modifying therapies. The new model, called SynNeurGe, classifies patients based on the presence or absence of alpha-synuclein protein clumps, detectable neurodegeneration, and Parkinson's-associated genetic mutations, providing a more holistic view of the disease and its causes. This approach could lead to more targeted treatment strategies and is considered a potential game changer for Parkinson's research and patient care.
